De-Escalation Strategies and Challenges With the Use of HET in Mild/Moderate Multiple Sclerosis


Multiple sclerosis (MS) treatment specialists discuss the challenges associated with the early use of high-efficacy therapy (HET) in patients with mild to moderate MS and delve into the broader debate surrounding the consistent use of HET for managing mild to moderate MS cases.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.